We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOOR
201
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$39.2M 0.16%
610,823
+472
+0.1% +$32.2K
CXP
202
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$39.1M 0.16%
1,654,904
-45,758
-3% -$1.06M
MET icon
203
MetLife
MET
$61B
$38.9M 0.16%
832,605
+7,951
+1% +$363K
WM icon
204
Waste Management
WM
$95.9B
$38.6M 0.15%
426,909
+380,632
+823% +$33.8M
ACWX icon
205
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$38.4M 0.15%
+806,085
New +$38.3M
AJG icon
206
Arthur J. Gallagher & Co
AJG
$63.7B
$38.3M 0.15%
514,461
-59,071
-10% -$4.24M
MAS icon
207
Masco
MAS
$16B
$37.6M 0.15%
1,027,750
-58,236
-5% -$2.24M
BLDR icon
208
Builders FirstSource
BLDR
$7.84B
$37.5M 0.15%
2,554,164
-74,241
-3% -$1.26M
PCG icon
209
PG&E
PCG
$47.8B
$36.9M 0.15%
801,545
+342,810
+75% +$15.3M
FOE
210
DELISTED
Ferro Corporation
FOE
$36.8M 0.15%
1,584,125
-45,171
-3% -$1M
HI
211
DELISTED
Hillenbrand
HI
$36.5M 0.15%
697,990
-20,655
-3% -$1.05M
MRCY icon
212
Mercury Systems
MRCY
$6.2B
$36.5M 0.15%
658,963
-471,051
-42% -$22.8M
SNN icon
213
Smith & Nephew
SNN
$12.9B
$36.4M 0.15%
981,472
-96
-0% -$3.46K
LTXB
214
DELISTED
LegacyTexas Financial Group Inc
LTXB
$36.4M 0.15%
854,159
-24,610
-3% -$1.08M
RWO icon
215
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
$36.3M 0.15%
762,041
-26,613
-3% -$1.29M
RF icon
216
Regions Financial
RF
$26.3B
$36.2M 0.14%
1,971,114
+1,090,297
+124% +$20.5M
TPH
217
DELISTED
Tri Pointe Homes
TPH
$36.1M 0.14%
2,912,252
-84,250
-3% -$1.25M
EFOR
218
Everforth Inc
EFOR
$845M
$36M 0.14%
455,770
-94,079
-17% -$8.13M
SPGI icon
219
S&P Global
SPGI
$126B
$35.6M 0.14%
182,394
+5,302
+3% +$1.09M
SCZ icon
220
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$35.4M 0.14%
+568,699
New +$35.5M
BLK icon
221
Blackrock
BLK
$164B
$35.4M 0.14%
75,074
+597
+0.8% +$290K
HSY icon
222
Hershey
HSY
$35.4B
$35.3M 0.14%
346,174
+205,578
+146% +$20.3M
KO icon
223
Coca-Cola
KO
$354B
$35.3M 0.14%
763,172
-29,046
-4% -$1.33M
ACHC icon
224
Acadia Healthcare
ACHC
$3.17B
$35.2M 0.14%
1,000,754
-27,722
-3% -$1.1M
BMY icon
225
Bristol-Myers Squibb
BMY
$127B
$34.9M 0.14%
562,588
+98,436
+21% +$5.84M

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.